Buy Sun Pharma, target price Rs 540: Suruchi Kapoor
The analyst suggested a stoploss at Rs 475.
Pharma emerges as most preferred sector among MFs
Earnings downgrade in the sector is likely to be the lowest among all sectors.
DART has a buy call on Sun Pharma, target price Rs 530
Resolution of the US drug price fixing probe will remove a major overhang on the stock...
Pharma shines in advance tax pay
When it comes to advance tax payments, pharma has emerged as one of the outliers with the sector showing a higher payout this quarter, while real estate, infrastructure, steel and cement were among segments that crumbled under the weight of the coronavirus-induced lockdown.
Government to curb pharma imports from China
Higher duties on Chinese products may also be on the cards, official sources said. These moves gathered pace in the wake of the military face-off between India and China in east Ladakh and the continuing diplomatic tension since then, prompting the government to explore all options to reduce import dependence on China.
Buy Sun Pharma, target price Rs 528: ICICI Securities
The brokerage expects US revenue growth to remain low in the near term with gradual ramp-up in the specialty portfolio offset by likely generic competition in Absorica in H2FY21.
Indian pharma compliance standards improving, regulatory risks here to stay: Ind-Ra
As Indian pharma accounts a significant share of the US generic market, Ind-Ra said it has seen increased scrutiny of the manufacturing facilities by US FDA over the last two years as the share of Indian generics products with higher complexity in the US market has increased.
Carlyle picks up 20% stake in Piramal pharma biz for $490 mn
The 20% stake sale values Piramal’s pharma business at Rs 20,000 crore.
Govt incentives will help Indian pharma cos reduce API imports from China: Tata Mutual Fund
‘We have a very strong presence in the formulation market’
Drug companies complain of hefty charges on stuck consignments from China
The pharma industry representatives ET spoke with said that while the customs department has been clearing containers of some drugs from China, consignments containing key starting material, active pharmaceutical ingredients (APIs) of vitamins, blood thinners and some critical drugs, etc., are still not cleared. Besides, port authorities are demanding demurrage charges.
Andhra Pradesh: Two dead, four injured in benzene gas leak at pharma plant in Vizag
Two people were killed and four others were taken ill after benzene gas leaked at a pharmaceutical company at Parawada near here early on Tu...
Why are pharma stocks rallying? Surajit Pal explains
‘The US market provides good revenue in dollars which is a bonus’
Roche Pharma India expands partnership with Cipla for key oncology medicines
Roche Pharma India has signed a "distribution agreement with Cipla to expand the scope of the partnership to include, marketing and distribution of its trademark oncology drugs - trastuzumab (Herclon), bevacizumab (Avastin) and rituximab (Ristova) in India," the company said in a statement.
Revival sign: Hiring up in some sectors
During lockdown, recruitment volumes were down nearly 80% for some firms as compared to pre-Covid levels.
Pharma sector flags shortage of packaging materials, transport
Having been exempted from the nation-wide lockdown as it came under essential services, the sector has accorded priority to meet the domestic requirements during the current scenario, according to office-bearers of the nearly 1,000 member strong IDMA.
Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service